TY - JOUR
T1 - Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis
AU - Schierwagen, Robert
AU - Maybüchen, Lara
AU - Zimmer, Sebastian
AU - Hittatiya, Kanishka
AU - Bäck, Christer
AU - Klein, Sabine
AU - Uschner, Frank E.
AU - Reul, Winfried
AU - Boor, Peter
AU - Nickenig, Georg
AU - Strassburg, Christian P.
AU - Trautwein, Christian
AU - Plat, Jogchum
AU - Lütjohann, Dieter
AU - Sauerbruch, Tilman
AU - Tacke, Frank
AU - Trebicka, Jonel
N1 - Funding Information:
Financial support: The study was supported by grants from Bonner Forum for Biomedicine (to JT/SZ), the Deutsche Forschungsgemeinschaft (SFB TRR57), BO 3755/1-1 and BO 3755/2-1(to PB), as well as from grants of H. J. & W. Hector Stiftung (to JT).
PY - 2015/8/11
Y1 - 2015/8/11
N2 - Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis, inflammation and fibrosis, which might progress to cirrhosis. Human NASH is associated with metabolic syndrome (MS). Currently, rodent NASH models either lack significant fibrosis or MS. ApoE -/- mice are a MS model used in cardiovascular research. The aim of this work was to establish and characterise a novel mouse NASH model with significant fibrosis and MS. ApoE -/- and wild-type mice (wt) were fed either a western-diet (WD), methionine-choline-deficient-diet (MCD) or normal chow. Liver histology, RT-PCR, hepatic hydroxyproline content, triglycerides and cholesterol levels, and fasting glucose levels assessed hepatic steatosis, inflammation and fibrosis. Further, portal pressure was measured invasively, and kidney pathology was assessed by histology. ApoE -/- mice receiving WD showed abnormal glucose tolerance, hepatomegaly, weight gain and full spectrum of NASH including hepatic steatosis, fibrosis and inflammation, with no sign of renal damage. MCD-animals showed less severe liver fibrosis, but detectable renal pathological changes, besides weight loss and unchanged glucose tolerance. This study describes a murine NASH model with distinct hepatic steatosis, inflammation and fibrosis, without renal pathology. ApoE -/- mice receiving WD represent a novel and fast model with all characteristic features of NASH and MS well suitable for NASH research.
AB - Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis, inflammation and fibrosis, which might progress to cirrhosis. Human NASH is associated with metabolic syndrome (MS). Currently, rodent NASH models either lack significant fibrosis or MS. ApoE -/- mice are a MS model used in cardiovascular research. The aim of this work was to establish and characterise a novel mouse NASH model with significant fibrosis and MS. ApoE -/- and wild-type mice (wt) were fed either a western-diet (WD), methionine-choline-deficient-diet (MCD) or normal chow. Liver histology, RT-PCR, hepatic hydroxyproline content, triglycerides and cholesterol levels, and fasting glucose levels assessed hepatic steatosis, inflammation and fibrosis. Further, portal pressure was measured invasively, and kidney pathology was assessed by histology. ApoE -/- mice receiving WD showed abnormal glucose tolerance, hepatomegaly, weight gain and full spectrum of NASH including hepatic steatosis, fibrosis and inflammation, with no sign of renal damage. MCD-animals showed less severe liver fibrosis, but detectable renal pathological changes, besides weight loss and unchanged glucose tolerance. This study describes a murine NASH model with distinct hepatic steatosis, inflammation and fibrosis, without renal pathology. ApoE -/- mice receiving WD represent a novel and fast model with all characteristic features of NASH and MS well suitable for NASH research.
UR - https://www.scopus.com/pages/publications/84939172436
U2 - 10.1038/srep12931
DO - 10.1038/srep12931
M3 - Article
C2 - 26263022
AN - SCOPUS:84939172436
SN - 2045-2322
VL - 5
JO - Scientific Reports
JF - Scientific Reports
M1 - 12931
ER -